This announcement is a separate document:
メドレックス：Alto-101 臨床第２相試験開始のお知らせ
Medrx: Announcements of individual stocks: Notice of the start of the Alto-101 Phase II clinical trial.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.